Development and delivery of personalized 3D-printed drugs to improve treatment adherence in children with rare diseases.
This research is looking into a new way to give medicines to children with very rare diseases, specifically methylcrotonylglycinuria and biotinidase deficiency. The study is called 'Development and delivery of personalised 3D-printed drugs to improve treatment adherence in children with rare diseases.' The goal is to create custom-made medicines using 3D printing, which could make it easier for children to take their medication as prescribed. This is important because consistently taking medicine (adherence) is key to managing long-term conditions. Researchers will be checking if these 3D-printed drugs help children feel better, by asking about their symptoms and using simple scales. They will also measure certain substances in the blood to see how well the medicine is working.
At a glance
What is this study about?
This study is trying out a very new and exciting way to give medicines to children who have rare diseases, like methylcrotonylglycinuria or biotinidase deficiency. Imagine a medicine that is made just for you, in a way that’s easier to take than standard tablets. That’s what 'personalised 3D-printed drugs' mean. The idea is that if medicine is easier and nicer for children to take, they are more likely to take it regularly, which is incredibly important for managing their health conditions well over time.
The main goal of this study is to see if these specially made 3D-printed medicines help children feel better. The doctors and nurses will ask children and their families about their symptoms and use simple scales to understand how they are feeling day-to-day. They will also look at how consistently the children are taking their medicines. This is a 'Phase III' study, which means it's a later stage of research, testing if these new methods are effective and safe on a larger group of people, after earlier stages have shown promise.
Ultimately, if this study shows good results, it could mean a big step forward for children with rare diseases, making their treatment journey a little bit easier and, hopefully, leading to better health outcomes in the long run. The conditions they are focusing on, methylcrotonylglycinuria and biotinidase deficiency, are serious and require ongoing treatment, so finding improved ways to deliver that treatment is very important.
Key takeaways
- New way to give medicine to children with rare diseases.
- Using 3D printing for personalized drug delivery.
- Focuses on methylcrotonylglycinuria and biotinidase deficiency.
- Aims to make it easier for children to take their medication regularly.
- Researchers will monitor how children feel and specific blood levels.
- This is a later-stage study (Phase III) testing effectiveness.
Who may be eligible?
To explore whether you or your child might be able to join this study, the researchers are looking for children with specific rare conditions: methylcrotonylglycinuria or biotinidase deficiency.
Both boys and girls of any age can be considered for this study. The researchers will look at each potential participant carefully to make sure the study is a good fit for them and that it is safe for them to take part.
There might be other health details or specific requirements that doctors will need to check to confirm if someone is suitable. If you think your child has one of these conditions and you're interested, it's best to speak with your doctor or the study team.
- Does my child have methylcrotonylglycinuria?
- Does my child have biotinidase deficiency?
- Is my child currently receiving treatment for one of these conditions?
- Am I comfortable with my child having regular check-ups and potentially blood tests?
- Am I interested in a new way for my child to take their medicine?
This is a guide only — the research team will confirm whether you can take part.
What does participation involve?
If you or your child decide to take part in this study, you would be trying out a new form of an existing medicine, either BIOTIN, Medebiotin Fuerte injectable solution, or Medebiotín Fuerte tablets, but possibly in a 3D-printed format. The study aims to see how well these specially made drugs work. You would have regular visits where doctors would check on your or your child's health and how the medicine is affecting your symptoms. This would involve answering questions about how you or your child are feeling and using easy-to-understand scales to describe any symptoms. There would also be occasional blood tests to check levels of certain substances, like organic acids and biotin, to see how the treatment is working inside the body. The total length of time you would be involved in the study would be explained by the study team, along with the schedule of visits and what each visit would involve.
Potential risks and benefits
Locations (1)
- —Spain
Common questions
What kind of conditions is this study for?
This study is for children who have rare genetic conditions called methylcrotonylglycinuria or biotinidase deficiency.
What are personalized 3D-printed drugs?
They are medicines made specially for an individual using 3D printing technology, hopefully making them easier to take.
Will my child get a new medicine?
The study uses existing medicines (BIOTIN, Medebiotin Fuerte) but explores delivering them in a new, potentially easier-to-take 3D-printed form.
What will doctors be checking in the study?
They will ask about symptoms, use visual scales to see how your child feels, and do blood tests to check how well the medicine is working.
Can I stop participating in the study if I want to?
Yes, you can choose to leave the study at any time, and it won't affect your child's regular medical care.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.